These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 18176073)

  • 21. Factor VIII-hydrolyzing IgG in acquired and congenital hemophilia.
    Wootla B; Mahendra A; Dimitrov JD; Friboulet A; Borel-Derlon A; Rao DN; Uda T; Borg JY; Bayry J; Kaveri SV; Lacroix-Desmazes S
    FEBS Lett; 2009 Aug; 583(15):2565-72. PubMed ID: 19595998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bleeding in the patient with a malignancy: is it an acquired factor VIII inhibitor?
    Escobar MA
    Cancer; 2012 Jan; 118(2):312-20. PubMed ID: 21720995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rituximab for the treatment of juvenile dermatomyositis: a report of four pediatric patients.
    Cooper MA; Willingham DL; Brown DE; French AR; Shih FF; White AJ
    Arthritis Rheum; 2007 Sep; 56(9):3107-11. PubMed ID: 17763414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Acquired factor VIII hemophilia in a geriatric patient].
    Boddi W; Machetti S; Sodi N; Sammicheli L; Cati G; Marotta G; Sabatini L; Cappelli R
    Ann Ital Med Int; 2005; 20(3):192-6. PubMed ID: 16250186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acquired factor VIII inhibitor.
    Simpson WG; Neefe J; Zang J; Drosick R; Kearns R
    J Ky Med Assoc; 1991 Nov; 89(11):555-7. PubMed ID: 1748831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rituximab in the treatment of acquired factor VIII inhibitors.
    Onitilo AA; Skorupa A; Lal A; Ronish E; Mercier RJ; Islam R; Lazarchick J
    Thromb Haemost; 2006 Jul; 96(1):84-7. PubMed ID: 16807656
    [No Abstract]   [Full Text] [Related]  

  • 27. Solid tumors and factor VIII antibodies.
    Hauser I; Lechner K
    Thromb Haemost; 1999 Sep; 82(3):1005-7. PubMed ID: 10494753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. First report of real-time monitoring of coagulation function potential and IgG subtype of anti-FVIII autoantibodies in a child with acquired hemophilia A associated with streptococcal infection and amoxicillin.
    Takeyama M; Nogami K; Kajimoto T; Ogiwara K; Matsumoto T; Shima M
    Int J Hematol; 2018 Jan; 107(1):112-116. PubMed ID: 28597369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current management of acquired factor VIII inhibitors.
    Barnett B; Kruse-Jarres R; Leissinger CA
    Curr Opin Hematol; 2008 Sep; 15(5):451-5. PubMed ID: 18695367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Simultaneous development of factor V inhibitor and autoimmune thrombocytopenia in a patient with dermatomyositis].
    Takaku T; Kuriyama Y; Shoji N; Otawa M; Gotoh A; Miyazawa K; Fukutake K; Ohyashiki K
    Rinsho Ketsueki; 2002 Dec; 43(12):1050-4. PubMed ID: 12607994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acquired hemophilia a in a patient with lumbar disc herniation: a case report and review of the literature.
    Li J; Shen H; Hou T; Li M; He S; Zhang H
    Spine (Phila Pa 1976); 2009 Apr; 34(8):E305-8. PubMed ID: 19365240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cholecystectomy and acquired factor VIII inhibitor coagulopathy.
    Walsh JD; Landercasper J; Bottner WA; Boyd WC
    Am Surg; 2004 Sep; 70(9):815-7. PubMed ID: 15481301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An acquired factor VIII inhibitor responsive to high-dose gamma globulin.
    Green D; Kwaan HC
    Thromb Haemost; 1987 Dec; 58(4):1005-7. PubMed ID: 2451304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spontaneous disappearance of high titre factor VIII inhibitor 15 years after unsuccessful ITI.
    Thom K; Male C; Falger J; Pabinger I
    Hamostaseologie; 2009 May; 29(2):149-50. PubMed ID: 19404512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Spontaneous ecchymosis disclosing acquired factor VIII inhibitor].
    Bayrou O; Deschamps A; Laurian C; Braunstein C; Leynadier F
    Ann Dermatol Venereol; 1993; 120(8):546-8. PubMed ID: 8304713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Acquired factor VIII inhibitor in a patient with rheumatoid arthritis].
    Ruiz-Calderón AJ; Carrasco F; Duro R; Constantino M
    Sangre (Barc); 1993 Oct; 38(5):403-5. PubMed ID: 8140505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cyclosporine A as an effective treatment for a patient with acquired hemophilia A complicated with diabetes mellitus and ischemic heart disease].
    Wano Y; Kang Y; Masaki H; Kawabata H; Fukushima T; Shimoyama K; Satoh A; Miyairi Y; Kashiwaba M; Hirose Y
    Rinsho Ketsueki; 2005 Oct; 46(10):1100-4. PubMed ID: 16440770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factor VIII genotype and inhibitor development in patients with haemophilia A: highest risk in patients with splice site mutations.
    Boekhorst J; Lari GR; D'Oiron R; Costa JM; Nováková IR; Ala FA; Lavergne JM; VAN Heerde WL
    Haemophilia; 2008 Jul; 14(4):729-35. PubMed ID: 18503540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Humoral immune responsiveness to a defined epitope on factor VIII before and after B cell ablation with rituximab.
    Kessel C; Königs C; Linde R; Escuriola-Ettinghausen C; Stoll H; Klingebiel T; Dietrich U; Kreuz W
    Mol Immunol; 2008 Nov; 46(1):8-15. PubMed ID: 18715645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kinetic parameters of monoclonal antibodies ESH2, ESH4, ESH5, and ESH8 on coagulation factor VIII and their influence on factor VIII activity.
    Egler C; Albert T; Brokemper O; Zabe-Kühn M; Mayer G; Oldenburg J; Schwaab R
    J Mol Recognit; 2009; 22(4):301-6. PubMed ID: 19266540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.